BDSX FY 2021 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

FY 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$55M+19.6% YoY

Gross Profit

$24M44.0% margin

Operating Income

-$41M-75.1% margin

Net Income

-$43M-79.2% margin

EPS (Diluted)

$-31.60

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$31M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$76M

Total Liabilities

$56M

Stockholders' Equity

$20M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$55M	$46M	+19.6%
Gross Profit	$24M	$24M	+1.8%
Operating Income	-$41M	-$23M	-78.5%
Net Income	-$43M	-$31M	-37.7%